Holen Sie sich die Stockscreener-App
11.56
0.69%
-0.08
Handel nachbörslich:
11.56
Schlusskurs vom Vortag:
$11.64
Offen:
$11.65
24-Stunden-Volumen:
1.15M
Relative Volume:
1.30
Marktkapitalisierung:
$1.23B
Einnahmen:
$247.00M
Nettoeinkommen (Verlust:
$-249.00M
KGV:
-3.7411
EPS:
-3.09
Netto-Cashflow:
$-267.00M
1W Leistung:
+8.95%
1M Leistung:
+25.24%
6M Leistung:
+19.30%
1J Leistung:
-29.17%
1-Tages-Spanne:
$11.28
$11.69
1-Wochen-Bereich:
$10.39
$11.84
52-Wochen-Spanne:
$6.50
$18.98
Arcus Biosciences Inc Stock (RCUS) Company Profile
Firmenname
Arcus Biosciences Inc
Sektor
Branche
Telefon
(510) 694-6200
Adresse
3928 POINT EDEN WAY, HAYWARD, CA
Vergleichen Sie RCUS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RCUS
Arcus Biosciences Inc
|
11.56 | 1.15B | 247.00M | -249.00M | -267.00M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-26 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-10-21 | Eingeleitet | H.C. Wainwright | Neutral |
| 2024-10-08 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-18 | Eingeleitet | BofA Securities | Neutral |
| 2022-10-11 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2020-11-24 | Eingeleitet | Berenberg | Buy |
| 2020-11-23 | Eingeleitet | Evercore ISI | Outperform |
| 2020-04-03 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-03-04 | Eingeleitet | Barclays | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-09-27 | Eingeleitet | Mizuho | Buy |
| 2019-05-24 | Fortgesetzt | Citigroup | Buy |
| 2018-10-09 | Eingeleitet | Wedbush | Outperform |
| 2018-04-09 | Eingeleitet | Citigroup | Buy |
| 2018-04-09 | Eingeleitet | Goldman | Neutral |
| 2018-04-09 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Arcus Biosciences Inc Aktie (RCUS) Neueste Nachrichten
Why Arcus Biosciences Inc. is moving todayPortfolio Update Summary & Risk Managed Trade Strategies - Newser
Candlestick signals on Arcus Biosciences Inc. stock today2025 Price Momentum & Daily Market Momentum Tracking - Newser
Published on: 2025-09-04 03:31:21 - Newser
Arcus Biosciences Inc.’s volatility index tracking explainedJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - Newser
Is Arcus Biosciences Inc. stock bottoming outMarket Performance Report & Free Accurate Trade Setup Notifications - Newser
Is Arcus Biosciences Inc. in a long term uptrendTrade Risk Assessment & Risk Managed Investment Entry Signals - khodrobank.com
What machine learning models say about Arcus Biosciences Inc.2025 Biggest Moves & Real-Time Volume Triggers - Newser
Sector ETF performance correlation with Arcus Biosciences Inc.2025 Analyst Calls & Risk Adjusted Swing Trade Ideas - Newser
Transcript : Arcus Biosciences, Inc. Presents at Citi's Biopharma Back to School Conference, Sep-03-2025 11 - MarketScreener
Arcus Biosciences shares rise 7.26% intraday after announcing an Investor Event to highlight new data for its HIF-2a inhibitor casdatifan. - AInvest
Will Arcus Biosciences Inc. see short term momentumJuly 2025 Setups & Technical Confirmation Trade Alerts - Newser
Smart tools for monitoring Arcus Biosciences Inc.’s price actionWeekly Profit Report & High Accuracy Swing Entry Alerts - Newser
Using Ichimoku Cloud for Arcus Biosciences Inc. technicalsJuly 2025 Market Mood & Safe Entry Trade Reports - Newser
Arcus Biosciences Inc. stock trend forecastTrade Signal Summary & High Win Rate Trade Tips - Newser
Leading vs lagging indicators on Arcus Biosciences Inc. performanceQuarterly Profit Report & Real-Time Buy Signal Notifications - Newser
Is Arcus Biosciences Inc. forming a bottoming baseJuly 2025 Review & Weekly High Potential Alerts - Newser
Strategies to average down on Arcus Biosciences Inc.July 2025 Outlook & Consistent Profit Alerts - Newser
Applying Wyckoff theory to Arcus Biosciences Inc. stock2025 Market Outlook & Real-Time Buy Zone Alerts - Newser
Arcus Biosciences Inc. stock daily chart insightsJuly 2025 Snapshot & Safe Capital Allocation Plans - Newser
Key Cancer Drug Trial Results Coming: Arcus Biosciences to Reveal Casdatifan Data for Kidney Cancer - Stock Titan
News impact scoring models applied to Arcus Biosciences Inc.July 2025 Patterns & Daily Profit Maximizing Tips - Newser
What moving averages say about Arcus Biosciences Inc.2025 Major Catalysts & Technical Entry and Exit Tips - Newser
What to do if you’re stuck in Arcus Biosciences Inc.Earnings Beat & AI Enhanced Execution Alerts - Newser
Backtesting results for Arcus Biosciences Inc. trading strategiesEarnings Growth Report & Free Fast Gain Swing Trade Alerts - Newser
Using Bollinger Bands to evaluate Arcus Biosciences Inc.2025 Market WrapUp & Safe Capital Allocation Plans - Newser
What recovery options are there for Arcus Biosciences Inc.July 2025 Institutional & Stepwise Swing Trade Plans - Newser
Is Arcus Biosciences Inc. stock a smart retirement pickQuarterly Portfolio Summary & Scalable Portfolio Growth Methods - khodrobank.com
Is Arcus Biosciences Inc. stock technically oversold2025 Bull vs Bear & Low Risk High Reward Trade Ideas - khodrobank.com
Is Arcus Biosciences Inc. forming higher highs and higher lows2025 Trading Volume Trends & Stock Portfolio Risk Management - khodrobank.com
Arcus Biosciences Inc. Outperforms Peers on Volume Metrics getLinesFromResByArray error: size == 0 - kangso.co.kr
What to expect from Arcus Biosciences Inc. in the next 30 daysEarnings Growth Report & Safe Capital Growth Plans - Newser
Chart overlay techniques for tracking Arcus Biosciences Inc.Quarterly Portfolio Report & Real-Time Volume Analysis - Newser
Arcus Biosciences Inc. stock retracement – recovery analysisJuly 2025 PostEarnings & Weekly Hot Stock Watchlists - Newser
Will Arcus Biosciences Inc. bounce back from current supportJuly 2025 Catalysts & Scalable Portfolio Growth Ideas - Newser
Trendlines Suggest Arcus Biosciences Inc. May Bottom Out Soon getLinesFromResByArray error: size == 0 - kangso.co.kr
Finanzdaten der Arcus Biosciences Inc-Aktie (RCUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):